Skip Standard Navigation Links
Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z
peer-reviewed.gif (582 bytes)
eid_header.gif (2942 bytes)
Past Issue

Vol. 12, No. 6
June 2006

Adobe Acrobat logo

EID Home | Ahead of Print | Past Issues | EID Search | Contact Us | Announcements | Suggested Citation | Submit Manuscript

PDF Version PDF Version | Comments Comments | Email this article Email this article



The Study
Conclusions
Acknowledgments
References
Figure
Table 1
Table 2

Dispatch

Preventing Zoonotic Influenza Virus Infection

Alejandro Ramirez,*†Comments Ana W. Capuano,* Debbie A. Wellman,* Kelly A. Lesher,* Sharon F. Setterquist,* and Gregory C. Gray*
*University of Iowa College of Public Health, Iowa City, Iowa, USA; and †Iowa State University College of Veterinary Medicine, Ames, Iowa, USA

Suggested citation for this article


We evaluated 49 swine industry workers and 79 nonexposed controls for antibodies to swine influenza viruses. Multivariate modeling showed that workers who seldom used gloves (odds ratio [OR] 30.3) or who smoked (OR 18.7) most frequently had evidence of previous H1N1 swine virus. These findings may be valuable in planning for pandemic influenza.

In the United States, influenza viruses are estimated to cause 36,000 human deaths and 200,000 hospitalizations annually (1–5). The current outbreaks of avian influenza in Asia and Eastern Europe remind us of the zoonotic potential of these viruses. Swine cells express sialic acids that can be receptors for swine, human, and avian influenza strains and facilitate cross-species influenza transmission and the genesis of novel influenza strains. Reported cases of human-to-swine and swine-to-human influenza transmission illustrate this potential (6,7).

Persons who work in enclosed livestock buildings (confinement workers) have among the highest risk of becoming infected with swine influenza virus. Their work involves close contact with many swine, including sick ones. The purpose of this cross-sectional study was to learn if these workers had evidence of previous swine influenza virus infection and, if so, to determine factors that cause them to be at increased risk.

The Study

Iowa is the top swine-producing state in the United States and markets ≈25 million swine a year. From November 2004 to March 2005, we recruited confinement workers. Site selection was based on the authors' community contacts and opportunities to invite workers to participate. Local veterinary clinics advertised the study and permitted enrollment at their facilities. This study was approved by the University of Iowa's institutional review board.

Persons were eligible to participate in the study if they had worked in a swine confinement facility in the past 12 months. Participants completed a questionnaire and permitted blood sample collection on enrollment. The questionnaire captured demographic, medical, and occupational data including influenza immunization history, swine occupational exposures, and use of protective equipment (gloves and masks). Nonexposed controls were enrolled during a concurrent study of University of Iowa faculty, staff, and students (8).

Serum samples were studied by using a hemagglutination inhibition (HI) assay against 2 recently circulating swine strains, A/Swine/WI/238/97 (H1N1) and A/Swine/WI/R33F/01 (H1N2), and 1 human influenza virus strain, A/New Caledonia/20/99 (H1N1). The swine H1N1 strain represents a lineage of virus that has been circulating among US swine for 70 years. The swine H1N2 strain first appeared in US swine in 1999. HI titer results are reported as the reciprocal of the highest dilution of serum that inhibited virus-induced hemagglutination of a 0.65% solution of guinea pig erythrocytes for human influenza and 0.5% solution of turkey erythrocytes for swine influenza.

Specimen laboratory results were examined for their statistical association with demographic, immunization, occupational, and other behavioral risk factors. Confinement workers were queried about the nature of their work and whether they had used protective equipment. Because incidence of high titers was low or nonexistent in most groups, H1N1 titers >10 were grouped. The resulting categories were <10, 10, and >10. Wilcoxon rank sum and χ2 statistic or 2-sided Fisher exact test were used to access bivariate risk factor associations. Depending on the nature of the data and modeling assumptions, proportional odds modeling or logistic regression was used to adjust for multiple risk factors. Final multivariate models were designed by using a saturated model and manual backwards elimination. Analyses were performed by using SAS version 9.1 (SAS Institute, Inc., Cary, NC, USA). Questionnaires were made available in both English and Spanish. Site selections were based on personal contacts in 3 completely different areas.

Forty-nine confinement workers and 79 nonexposed controls were enrolled in the study. The distribution of ages was similar for the 2 groups, but the confinement workers were more likely to be male and Hispanic and less likely to have received influenza vaccination (Table 1).

Swine confinement workers were categorized by type of work, frequency of contact with swine, use of gloves, and use of masks. The question "When working with sick or diseased swine, how often do you wear gloves?" explained the most variation in swine H1N1 antibody titers and was included in the best fit model. Workers who sometimes or never used gloves were significantly more likely (odds ratio [OR] 30.3, 95% confidence interval [CI] 3.8–243.5) to have elevated titers than the nonexposed controls (Table 2). These workers also were significantly more likely (OR 12.7, 95% CI 1.1–151.1) (data not shown) to have elevated titers than the other confinement workers who used gloves most of the time or always. Workers who reported smoking also had high OR (data not shown) for elevated titers.

Figure
Figure.

Click to view enlarged image

Figure. Variation in serologic response against swine H1N1 influenza virus and frequency of glove use by swine workers.

Multivariate analysis also showed that persons who had received the 2003–04 influenza vaccine were significantly more likely to have elevated titers (>10) against swine H1N1 virus (Table 2) as well as swine H1N2 (data not shown). Although cross-reaction with 1 of the viruses in the 2003–04 vaccine or a circulating influenza virus may explain this occurrence, higher titers would have been expected for all vaccinated persons (including controls), but such higher titers were not observed (Figure). We suggest that this result represents other behavior or health-related confounders not identified in the questionnaire for this study.

Conclusions

These data suggest, like previous studies (8–10), that swine confinement workers are at increased risk for zoonotic influenza infection. However, our data are among the first to evaluate swine confinement workers, our sample size was small (not likely representative of all swine workers), and exposure data were self-reported. Confinement workers, in contrast to other swine occupations, are difficult to reach because of language barriers, on-farm policies regarding visitors (biosecurity protocols), and lack of trust in the public health sector.

Several studies have documented smoking as a risk factor for human influenza virus infection (11–13). However, we believe our data are the first evidence that smoking also increases the risk for swine influenza virus infections. We believe that this increased risk may be because the workers' oral mucosa are exposed to swine influenza virus after handling pigs.

This study's chief unique contribution is the evidence that use of gloves during swine confinement work noticeably decreases the risk for swine influenza virus infection. Thus, a simple personal protective measure might do much to reduce swine-to-human virus transmission. Future larger studies of swine confinement workers are needed to validate our findings and to better quantify risk factors for this population.

Individual behavior strongly influences influenza virus transmission (5). The national strategy for pandemic influenza highlights worker education and emphasizes individual responsibilities in preventing the spread of infection (14). Should a virulent, novel zoonotic influenza virus enter swine confinement facilities and spread among concentrated swine populations, the impact would be grave. Surveillance for zoonotic influenza virus therefore must be routinely conducted among agricultural workers. Also, use of personal protective equipment, frequent hand washing, and restrictions on smoking in or around swine facilities should be encouraged. Further, such workers should be included in state and federal pandemic plans as a high-risk group designated to receive annual influenza vaccines and antiviral drugs during pandemics.

Acknowledgments

We thank the veterinarians and staff from Valley Veterinary Center and the Winthrop Veterinary Clinic for use of their facilities for this project; James Miller and Hector Hernandez for their assistance in recruiting study subjects; the phlebotomists who volunteered to help with this project, especially Amy Kapanka and Carrie Ducommun; Kendall Myers for her assistance with study data; Christopher Olsen for providing swine viruses; Alexander Klimov for providing human viruses; and James Roth and the staff at the Center for Food Security and Public Health for their support.

This work was funded by the University of Iowa's Center for Emerging Infectious Diseases. Serologic assay work was funded in part by a grant from the National Institutes of Allergy and Infectious Diseases (NIAID-R21 AI059214-01).

Dr Ramirez is a veterinary specialist in the swine production medicine group in the Department of Veterinary Diagnostic and Production Animal Medicine at Iowa State University's College of Veterinary Medicine. This research project served to partially meet the academic requirements for his master's degree in public health.

References

  1. Murphy B, Webster RG. Orthomyxoviruses. In: Fields BN, Knipe DM, Howley PM, Chanock RM, Melnick JL, Monath TP, et al., editors. Fields virology. 3rd ed. New York: Raven Press; 1996. p. 1397-445.
  2. Simonsen L, Clarke MJ, Williamson GD, Stroup DF, Arden NH, Schonberger LB. The impact of influenza epidemics on mortality: introducing a severity index. Am J Public Health. 1997;87:1944–50.
  3. Bridges CB, Fukuda K, Cox NJ, Singleton JA. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2001;50(RR-4):1–44.
  4. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289:179–86.
  5. Homeland Security Council. National strategy for pandemic influenza. 2005 [cited 2006 Apr 14]. Available from http://www.whitehouse.gov/homeland/pandemic-influenza.html#section3
  6. Alexander DJ, Brown IH. Recent zoonoses caused by influenza A viruses. Rev Sci Tech. 2000;19:197–225.
  7. Brown IH. The epidemiology and evolution of influenza viruses in pigs. Vet Microbiol. 2000;74:29–46.
  8. Myers KP, Olsen CW, Setterquist SF, Capuano AW, Donham KJ, Thacker EL, et al. Are swine workers in the United States at increased risk of infection with zoonotic influenza virus? Clin Infect Dis. 2006:42;14–20.
  9. Woods GT, Schnurrenberger PR, Martin RJ, Tompkins WA. Swine influenza virus in swine and man in Illinois. J Occup Med. 1981;23:263–7.
  10. Olsen CW, Brammer L, Easterday BC, Arden N, Belay E, Baker I, et al. Serologic evidence of H1 swine influenza virus infection in swine farm residents and employees. Emerg Infect Dis. 2002;8:814–9.
  11. Finklea JF, Sandifer SH, Smith DD. Cigarette smoking and epidemic influenza. Am J Epidemiol. 1969;90:390–9.
  12. Arcavi L, Benowitz NL. Cigarette smoking and infection. Arch Intern Med. 2004;164:2206–16.
  13. Kark JD, Lebiush M, Rannon L. Cigarette smoking as a risk factor for epidemic a(h1n1) influenza in young men. N Engl J Med. 1982;307:1042–6.
  14. US Department of Health and Human Services. HHS Pandemic Influenza Plan 2005 [cited 2006 Apr 14]. Available from http://www.hhs.gov/pandemicflu/plan/pdf/HHSPandemicInfluenzaPlan.pdf

 

Table 1. Characteristics of swine workers and controls, Iowa, 2004–2005


Variable

Total

Study sample, n (%)


Swine workers (n = 49)

Controls (n = 79)*


Age group (y)

 

<29

46

15 (30.6)

31 (39.2)

29–42

40

12 (24.5)

28 (35.4)

>42

42

22 (44.9)

20 (25.3)

Mean age (y)

40.3

35.3

Sex†

 

Male

63

37 (75.5)

26 (32.9)

Female

65

12 (24.5)

53 (67.1)

Race†

 

American Indian/Alaska Native

1

0

1 (1.3)

Asian

2

1 (2)

1 (1.3)

African American

18

0

18 (22.8)

Native Hawaiian/Other Pacific Islander

2

0

2 (2.5)

White

105

48 (98)

57 (72.2)

Ethnicity†

 

Hispanic/Latino

12

10 (21.7)

2 (2.5)

Non-Hispanic/Latino

113

36 (78.3)

77 (97.5)

Served in military

 

Yes

12

5 (10.4)

7 (8.9)

No

115

43 (89.6)

72 (91.1)

Take medications that weaken immune system

 

Yes

3

2 (4.2)

1 (1.3)

No

122

44 (91.7)

78 (98.7)

Do not know

2

2 (4.2)

0 (0)

Have heart or vascular disease

 

Yes

3

2 (4.2)

1 (1.3)

No

124

46 (95.8)

78 (98.7)

Have any chronic lung problems such as asthma or emphysema

 

Yes

5

2 (4.2)

3 (3.8)

No

122

46 (95.8)

76 (96.2)

Received the 2001–02 influenza vaccine

 

Yes

37

6 (12.5)

31 (39.2)

No

90

42 (87.5)

48 (60.8)

Received the 2002–03 influenza vaccine†

 

Yes

36

5 (10.4)

31 (39.2)

No

91

43 (89.6)

48 (60.8)

Received the 2003–04 influenza vaccine†

 

Yes

43

8 (16.7)

35 (44.3)

No

84

40 (83.3)

44 (55.7)

Received the 1976–77 influenza vaccine†

 

Yes

2

1 (2.1)

1 (1.3)

No

119

41 (85.4)

78 (98.7)

Do not know

6

6 (12.5)

0

Smoked >5 packs of cigarettes in past year†

 

Yes

14

9 (18.4)

5 (6.3)

No

114

40 (81.6)

74 (93.7)


*Not exposed to swine.

†Significantly different than controls at α = 0.05.

 

Table 2. Odds ratios for increased serologic response against swine H1N1 influenza virus by hemagglutination inhibition assay


Variable

n

Swine H1N1*


Titer >10, n (%)

Titer >20, n (%)

Bivariate OR (95% CI)

Multivariate OR (95% CI)


Age group (y)

 

<29

40

3 (7.5)

1 (2.5)

1.2 (0.2–6.1)

3.5 (0.4–30.6)

29–42

46

3 (6.5)

1 (2.2)

Reference

Reference

>42

42

9 (22)

6 (14.6)

4.2 (1.1–16.8)†

6.1 (0.9–41.3)

Sex

 

Male

63

13 (21)

7 (11.3)

8.4 (1.8–38.7)†

7 (0.9–52.1)

Female

65

2 (3.1)

1 (1.5)

Reference

Reference

Swine exposure

 

Swine workers occasionally or never use gloves

34

12 (35.3)

7 (20.6)

21 (4.4–100.8)†

30.3 (3.8–243.5)†

Swine workers usually or always use gloves

14

1 (7.1)

0

2.8 (0.2–34.2)

2.4 (0.1–40.9)

Controls not exposed to swine

79

2 (2.6)

1 (1.3)

Reference

Reference

Smoked >5 packs of cigarettes in past year

 

Yes

14

4 (28.6)

3 (21.4)

4 (1.1–14.5)†

18.7 (2.5–141.3)†

No

114

11 (9.7)

5 (4.4)

Reference

Reference

Received 2002–03 influenza vaccine

 

Yes

36

4 (11.4)

1 (2.9)

1 (0.3–3.4)

No

91

10 (11)

7 (7.7)

Reference

Received 2003–04 influenza vaccine

 

Yes

43

6 (14.3)

3 (7.1)

1.6 (0.5–4.8)

16.3 (2.5–107.4)†

No

84

8 (9.5)

5 (6)

Reference

Reference

Elevated titer human H1N1 (>40)

 

Positive

39

2 (5.3)

1 (2.6)

0.3 (0.1–1.5)

Negative

89

13 (14.6)

7 (7.9)

Reference


*OR, odds ratio; CI, confidence interval; by using proportional odds model, these titers were grouped: <10, 10, >10.

†Significant odds for increased serologic response, p<0.05.

 

Suggested citation for this article:
Ramirez A, Capuano AW, Wellman DA, Lesher KA, Setterquist SF, Gray GC. Preventing zoonotic influenza virus infection. Emerg Infect Dis [serial on the Internet]. 2006 Jun [date cited]. Available from http://www.cdc.gov/ncidod/EID/vol12no06/05-1576.htm

   
     
   
Comments to the Authors

Please use the form below to submit correspondence to the authors or contact them at the following address:

Alejandro Ramirez, Iowa State University College of Veterinary Medicine, Veterinary Diagnostic and Production Animal Medicine, 1710 College of Veterinary Medicine, Ames, IA 50011, USA; email: ramireza@iastate.edu

Please note: To prevent email errors, please use no web addresses, email addresses, HTML code, or the characters <, >, and @ in the body of your message.

Return email address optional:


 


Comments to the EID Editors
Please contact the EID Editors at eideditor@cdc.gov

Email this article

Please note: To prevent email errors, please use no web addresses, email addresses, HTML code, or the characters <, >, and @ in the body of your message.

Your email:

Your friend's email:

Message (optional):

 

 

 

EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z

This page posted May 16, 2006
This page last reviewed May 19, 2006

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention